Flora Growth CEO to Deliver Keynote Address at Plant Medicine Week Conference in Malta
Flora Growth Corp. (NASDAQ: FLGC) announced that its CEO Luis Merchan will be the keynote speaker at the upcoming Plant Medicine Week conference in Valletta, Malta from April 5-8. His speech, titled “Malta - The Gateway to South American and European Cannabis Relations,” will highlight Malta's cannabis stance and the advantages of South American cultivation. Flora aims to foster relationships within the EU cannabis sector and discuss sustainable cultivation practices. The company's outdoor cannabis facility supports diverse sectors including cosmetics and food.
- Luis Merchan's keynote speech highlights growth opportunities in European cannabis relations.
- Flora's outdoor cultivation practices position it well in cost-effective cannabis production.
- Participation in the Plant Medicine Week conference enhances Flora's visibility and potential partnerships.
- None.
Merchan’s keynote speech at the conference, entitled, “Malta - The
The Plant Medicine Week conference in
“I’m honored to be keynote speaker at the Plant Medicine Week conference this year in Malta,”
About
Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands designed to deliver the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. Visit www.floragrowth.com or follow @floragrowthcorp on social media for more information.
Cautionary Statement Concerning Forward-Looking Statements
This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: expected future revenue, the proposed acquisition of Vessel; Vessel’s financial performance; our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking events discussed in this document and other statements made from time to time by us or our representatives not occurring, except as may be required by applicable law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220330005364/en/
Investor Relations:
James.Williams@FloraGrowth.com
Public Relations:
+1 (858) 264-6600
flora@cmwmedia.com
Source:
FAQ
What is Flora Growth's stock symbol?
When is the Plant Medicine Week conference where Flora Growth's CEO will speak?
What will Flora Growth CEO Luis Merchan discuss at the conference?
Where is the Plant Medicine Week conference being held?